Evidence map›Paper›PMID 32003159›Full record

ArticleJournal of the International AIDS Society2020

Characterizing the double-sided cascade of care for adolescents living with HIV transitioning to adulthood across Southern Africa.

Priscilla R Tsondai, Annette H Sohn, Sam Phiri, Kombatende Sikombe, Shobna Sawry, Cleophas Chimbetete, Geoffrey Fatti, Michael A Hobbins, Karl-Günter Technau, Helena Rabie and 6 more

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. "AIDS care · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Priscilla R TsondaiCentre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-6637-5820
Annette H SohnTREAT Asia/amfAR - The Foundation for AIDS Research, Bangkok, Thailand.ORCID 0000-0002-0209-3285
Sam PhiriLighthouse Trust Clinic, Lilongwe, Malawi.
Kombatende SikombeCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Shobna SawryHarriet Shezi Children's Clinic, Wits Reproductive Health and HIV Research Unit, University of Witwatersrand, Johannesburg, South Africa.ORCID 0000-0002-3845-4863
Cleophas ChimbeteteNewlands Clinic, Harare, Zimbabwe.
Geoffrey FattiKheth'Impilo, Cape Town, South Africa.ORCID 0000-0002-6467-662X
Michael A HobbinsSolidarMed, Luzern, Switzerland.
Karl-Günter TechnauEmpilweni Services and Research Unit, Department of Paediatrics & Child Health, Rahima Moosa Mother and Child Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.ORCID 0000-0001-7367-7512
Helena RabieDepartment of Paediatrics and Child Health, Tygerberg Academic Hospital, University of Stellenbosch, Stellenbosch, South Africa.
Jonathan BernheimerMédecins Sans Frontiers, Khayelitsha, South Africa.
Matthew P FoxDepartment of Global Health and Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.ORCID 0000-0001-9887-0634
Ali JuddMRC Clinical Trials Unit at UCL, University College London (UCL), London, United Kingdom.ORCID 0000-0003-3176-5295
Intira J CollinsMRC Clinical Trials Unit at UCL, University College London (UCL), London, United Kingdom.ORCID 0000-0003-2132-6037
Mary-Ann DaviesCentre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.ORCID 0000-0001-8496-6475
International epidemiology to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration

Funding

Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
Creating a Global fRAmework of Data collection Used for Adolescent HIV Transition Evaluation (GRADUATE)R21HD089859 · NICHD · FOUNDATION FOR AIDS RESEARCH · PI DAVIES, MARY-ANN, SOHN, ANNETTE H · 2016 to 2017
$268k
Medical Research Council MC_UU_12023/17Medical Research Council MC_UU_12023/26NIAID NIH HHS U01 AI069924NICHD NIH HHS R21 HD089859
6 · The paper itself

Abstract

introductionAs adolescents and young people living with HIV (AYLH) age, they face a "transition cascade," a series of steps associated with transitions in their care as they become responsible for their own healthcare. In high-income countries, this usually includes transfer from predominantly paediatric/adolescent to adult clinics. In sub-Saharan Africa, paediatric HIV care is mostly provided in decentralized, non-specialist primary care clinics, where "transition" may not necessarily include transfer of care but entails becoming more autonomous for one's HIV care. Using different age thresholds as proxies for when "transition" to autonomy might occur, we evaluated pre- and post-transition outcomes among AYLH.

methodsWe included AYLH aged <16 years at enrolment, receiving antiretroviral therapy (ART) within International epidemiology Databases to Evaluate AIDS Southern Africa (IeDEA-SA) sites (2004 to 2017) with no history of transferring care. Using the ages of 16, 18, 20 and 22 years as proxies for "transition to autonomy," we compared the outcomes: no gap in care (≥2 clinic visits) and viral suppression (HIV-RNA <400 copies/mL) in the 12 months before and after each age threshold. Using log-binomial regression, we examined factors associated with no gap in care (retention) in the 12 months post-transition.

resultsA total of 5516 AYLH from 16 sites were included at "transition" age 16 (transition-16y), 3864 at 18 (transition-18y), 1463 at 20 (transition-20y) and 440 at 22 years (transition-22y). At transition-18y, in the 12 months pre- and post-transition, 83% versus 74% of AYLH had no gap in care (difference 9.3 (95% confidence interval (CI) 7.8 to 10.9)); while 65% versus 62% were virally suppressed (difference 2.7 (-1.0 to 6.5%)). The strongest predictor of being retained post-transition was having no gap in the preceding year, across all transition age thresholds (transition-16y: adjusted risk ratio (aRR) 1.72; 95% CI (1.60 to 1.86); transition-18y: aRR 1.76 (1.61 to 1.92); transition-20y: aRR 1.75 (1.53 to 2.01); transition-22y: aRR 1.47; (1.21 to 1.78)).

conclusionsAYLH with gaps in care need targeted support to prevent non-retention as they take on greater responsibility for their healthcare. Interventions to increase virologic suppression rates are necessary for all AYLH ageing to adulthood.

Indexed as

AdolescentAdultAfrica, SouthernAmbulatory Care FacilitiesAnti-HIV AgentsChildFemaleHIV InfectionsHumansMaleYoung AdultAnti-HIV Agentsadolescentscascade of carehealthcare transitionHIVretentionviral suppressionyouth

Identifiers

PMID32003159
PMCPMC6992508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.